Glenna Mileson - Jan 18, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Financial Officer
Signature
/s/ Glenna Mileson
Stock symbol
ATHA
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 04:28 PM
Previous filing
Jan 6, 2022
Next filing
Apr 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +170K $0.00 170K Jan 18, 2022 Common Stock 170K $10.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares subject to the option will vest on February 18, 2022, and one forty-eighth of the shares subject to the option will vest each month thereafter.